Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2017)
Arbutus Biopharma (ABUS) posted Change in Taxes of $108000.0 for Q3 2017, little changed sequentially from $108000.0 in Q2 2017.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2017) Analysis & Trends
Arbutus Biopharma has reported Change in Taxes for 3 years, with the latest figure at $108000.0 in Q3 2017.
- Quarterly Change in Taxes changed N/A year-over-year to $108000.0 in Q3 2017, while the trailing twelve-month figure through Sep 2018 was $108000.0 (down 50.0% YoY) and the FY2017 annual result came in at $108000.0, changed N/A from the prior year.
- Change in Taxes was little changed at $108000.0 in Q3 2017 per ABUS's latest filing, from $108000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $108000.0 in Q2 2017 and troughed at $10000.0 in Q2 2013.
- A 3-year average of $62750.0 and a median of $66500.0 in 2015 frame the typical range for Change in Taxes.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arbutus Biopharma | 1.02 Bn | 927.31 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 108,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Jun 30, 2013 | 10,000.00 |